Cytokinetics Inc. buy Barclays PLC
Start price
24.04.25
/
50%
€33.60
Target price
24.04.26
€48.44
Performance (%)
59.23%
Price
20.03.26
€53.50
Summary
This prediction is currently active. With a performance of 59.23% the BUY prediction by Barclays_PLC is a big success. This prediction currently runs until 24.04.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 1.905% | 1.905% |
| iShares Core DAX® | -4.932% | -11.977% |
| iShares Nasdaq 100 | -2.634% | -2.218% |
| iShares Nikkei 225® | -4.733% | -10.900% |
| iShares S&P 500 | -2.544% | -3.540% |
Comments by Barclays_PLC for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $55.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Barclays_PLC for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€41.60
03.09.25
03.09.25
€61.04
03.09.26
03.09.26
28.61%
20.03.26
20.03.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.00
08.05.25
08.05.25
€46.79
08.05.26
08.05.26
84.48%
20.03.26
20.03.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€46.40
23.05.24
23.05.24
€87.72
23.05.25
23.05.25
-42.24%
24.05.25
24.05.25